This is a very rare and serious brain disease. It's caused by a long-term infection with the measles virus, usually years after the initial measles infection. It slowly gets worse over time, causing problems with thinking, behavior, and movement. It can lead to seizures, muscle stiffness, and eventually death.
Every report comes from a Lived member, sent anonymously.
Have you tried Inosine Pranobex for Subacute Sclerosing Panencephalitis?
Subacute sclerosing panencephalitis (SSPE) is a rare, progressive brain disease caused by the measles virus. It appears years after a person has had measles, usually in childhood or the teenage years. A changed form of the virus stays hidden in the brain after the original illness seems over, and it slowly spreads and damages brain tissue. The first changes are often subtle and easy to mistake for something else: slipping school performance, forgetfulness, irritability or a change in personality. Some people first show psychiatric symptoms or lose part of their vision. Over the following months, most develop sudden, repeated muscle jerks (myoclonus) that can cause falls, along with seizures, stiffness and trouble walking and speaking. In later stages a person can no longer move or communicate on their own. SSPE is now rare where measles vaccination is widespread, but cases rise again after measles outbreaks.
SSPE happens only in people who have had a natural measles infection. The greatest risk follows measles in early childhood, especially before age 2, when the immune system may fail to clear the virus completely. Symptoms usually begin around 6 to 8 years later, although the gap can be shorter or much longer. Some children had measles so mildly, or so young, that no one remembers it. Overall, SSPE affects a small fraction of people who get measles, but the risk is clearly higher when measles strikes in infancy. Babies too young to be vaccinated are most exposed when measles circulates in communities with low vaccination rates. Measles vaccination is the only proven way to prevent SSPE. Studies of the virus found in people with SSPE show that it comes from wild measles, not from the vaccine.
No single test diagnoses SSPE. Clinicians combine the pattern of symptoms with a few characteristic findings, and a history of measles, if known, strengthens suspicion. The key test is a lumbar puncture (spinal tap), which samples the fluid around the brain and spinal cord. In SSPE this fluid contains unusually high levels of antibodies against measles, showing that the immune system is fighting the virus inside the nervous system. An electroencephalogram (EEG), a recording of the brain's electrical activity, often shows large, regular bursts repeating every few seconds, frequently in time with the muscle jerks. A magnetic resonance imaging (MRI) scan can be normal early on; later it tends to show changes in the brain's white matter and shrinking of brain tissue. A brain biopsy is rarely needed. Because the early signs can look like a behavior or psychiatric problem, or like some types of epilepsy and other brain diseases, people are sometimes evaluated for those first. Eye examinations matter too, since the virus can damage the retina or optic nerve.
There is no established cure for SSPE, and no treatment reliably stops it. Care has two aims: trying to slow the disease, and keeping the person as comfortable and functional as possible. The most widely used disease-directed treatment is isoprinosine (inosine pranobex), an oral medicine that stimulates the immune system and has some antiviral activity. It is sometimes combined with interferon alpha, an immune-signaling protein that can be injected or delivered into the spinal fluid or brain. In studies, roughly a third to half of treated people stabilized or improved for a time, but these gains usually proved temporary and the evidence is limited. Isoprinosine is costly and not available everywhere. Antiviral drugs such as ribavirin have been given directly into the brain's fluid spaces through an implanted reservoir; some people improved, but the device carries a real risk of infection. Other medicines, including aprepitant, have not changed the course in trials. Symptom treatment helps in every case. Anti-seizure medicines, such as carbamazepine, levetiracetam, valproate or clobazam, can reduce the jerks and seizures. Physical therapy, help with feeding and communication, and palliative care, which focuses on comfort and support for the whole family, become more central as the disease advances.
SSPE is usually fatal, but its course varies widely and is hard to predict. Many people decline over one to a few years, often through stages: early mental and behavioral changes, then jerks and loss of movement and speech, then dependence on full-time care. Only a minority follow these stages in a steady line. More often there are periods of stability, occasional temporary improvement and sudden drops in ability. A small number live a decade or longer, sometimes with long plateaus, especially when the disease progresses slowly or begins in adulthood. Daily life changes as the disease moves forward. Early on, a child may need school support and supervision because of falls and changing behavior. Later, help is needed with eating, moving, personal care and communication, and many families arrange care at home with nursing support. Regular follow-up with a neurology team helps adjust seizure treatment and plan for new needs. Planning ahead with the care team about goals of care, and finding support for parents and siblings, can make a very hard course more manageable.
Arrange a medical evaluation, and mention any past measles, if a child or young adult shows a steady decline in school performance or memory, a lasting change in behavior or personality, repeated sudden jerks or falls, or unexplained loss of vision. A neurologist can decide whether tests for SSPE are needed. For someone already diagnosed, contact the care team promptly about new or more frequent seizures, a fever, or a sudden loss of abilities after a stable period, since the disease can change quickly and treatment or care plans may need adjusting.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share what living with Subacute Sclerosing Panencephalitis is like, what's helped you, or ask the community a question.